The demand for safe transfusion blood is driven by the rising global prevalence of blood disorders, increased incidents of road accidents and surgeries, and the growing geriatric population.
WILMINGTON, Del., July 25, 2024 /PRNewswire/ -- The global blood transfusion diagnostics market stood at US$ 4.6 billion in 2023, and the global market is projected to reach US$ 7.7 billion in 2034. The global blood transfusion diagnostics market is anticipated to expand at a CAGR of 4.9% between 2024 and 2034.
The rising global prevalence of blood disorders, such as anemia, hemophilia, and leukemia, necessitates the need for accurate and reliable diagnostic tests to assess blood compatibility and identify potential risks associated with transfusions.
Additionally, the surge in road accidents and surgical procedures further drives the demand for blood transfusions, emphasizing the importance of stringent screening and compatibility testing to prevent adverse reactions and ensure patient safety.
Moreover, the growing geriatric population, who are more prone to chronic illnesses and require frequent medical interventions, contributes to the escalating demand for blood transfusion diagnostics.
Download Sample PDF Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85892
Elderly individuals often require blood transfusions as part of their treatment regimens, underscoring the critical role of diagnostic tests in assessing blood suitability and minimizing transfusion-related complications.
Furthermore, the increasing focus on collaborations and partnerships between healthcare entities and research institutions plays a pivotal role in expanding the adoption of advanced blood transfusion diagnostics.
These collaborations aim to enhance diagnostic technologies, develop innovative testing methodologies, and streamline transfusion protocols to improve patient outcomes and ensure the safety and efficacy of blood transfusions.
Technological advancements in blood transfusion diagnostics, such as the development of automated platforms, molecular testing techniques, and point-of-care devices, further drive market growth by offering rapid, accurate, and cost-effective testing solutions.
The innovative technologies enable healthcare professionals to perform comprehensive blood compatibility assessments, detect infectious agents, and identify potential immunological reactions more efficiently, thereby facilitating timely and informed transfusion decisions.
The blood transfusion diagnostics market is poised for continued expansion as the demand for safe and effective transfusion practices escalates worldwide. With ongoing advancements in diagnostic technologies and increased collaboration efforts within the healthcare industry, the market is expected to witness significant growth opportunities in the coming years, ensuring the delivery of high-quality transfusion services and improving patient care outcomes.
Blood Transfusion Diagnostics Market Report Scope:
Report Coverage | Details |
Forecast Period? | 2024-2034 |
Base Year? | 2020-2022 |
Size in 2023 | US$ 4.6 Bn |
Forecast (Value) in 2034 | US$ 7.7 Bn |
Growth Rate (CAGR) | 4.9 % |
No. of Pages | 225 Pages |
Segments covered | By Product Type, By Application, By Region, By End-user |
Key Takeaways of Market Report
- Global blood transfusion diagnostics market to generate absolute dollar opportunity worth US$ 7.7 billion until 2034.
- Global blood transfusion diagnostics market is valued at US$ 4.6 billion in 2023.
- North America is forecasted to hold the largest market share.
Global Blood Transfusion Diagnostics Market: Growth Drivers
- Technological advancements in blood donor management systems, particularly the emergence of automated systems, have revolutionized workflows, enhancing efficiency and accuracy.
- Donor recruitment and engagement technologies, including innovative software and mobile applications, play a pivotal role in reaching potential donors, scheduling appointments, sending reminders, and providing post-donation care instructions. This improves donor engagement, enhances the overall donor experience, and boosts donor retention rates.
- The increasing prevalence of blood-related disorders like leukemia, thalassemia, sickle cell anemia, and hemophilia drives the demand for safe transfusion blood, fueling the growth of the blood transfusion diagnostics market.
Global Blood Transfusion Diagnostics Market: Regional Landscape
- North America held a dominant share in the blood transfusion diagnostics market, driven by advancements in healthcare infrastructure, increased awareness, and augmented healthcare finances. In the United States, companies like Roche are launching innovative transfusion diagnostics solutions, such as the cobas Malaria test, FDA-approved in March 2024, to reduce the risk of malarial infection from transfused blood products.
- In the European Union, the rising prevalence of diseases like sickle cell anemia is spurring efforts by medical device manufacturers and the government to improve transfusion blood availability, thereby driving market growth in Europe.
Request Table of Content Here:
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=85892
Global Blood Transfusion Diagnostics Market: Key Players
- In 2023, Prestige Diagnostics introduced a cutting-edge blood transfusion diagnostics platform designed to enhance the accuracy and efficiency of blood compatibility testing. This innovative solution incorporates advanced molecular testing techniques and automated workflows to streamline the transfusion process, ensuring compatibility and safety for patients receiving blood transfusions.
- In 2023, Atlas Medical launched a revolutionary point-of-care blood transfusion diagnostics device capable of rapid and reliable testing for blood type compatibility and infectious diseases. This portable device enables healthcare professionals to perform on-site testing with minimal turnaround time, facilitating timely and informed transfusion decisions and improving patient outcomes in diverse healthcare settings.
Global Blood Transfusion Diagnostics Market: Segmentation
Product Type
- Instruments
- Blood Grouping Instruments
- Others
- Kits and Reagents
- Blood Grouping Kits and Reagents
- Others
Application
- Blood Grouping
- ABO Blood Grouping
- Rh Blood Grouping
- Red Blood Cell Antibody Screening
- Extended Phenotyping
- Cross Matching Tests
- Disease Screening
- Molecular Disease Screening
- Serological Disease Screening
End User
- Blood Banks
- Blood Donation/Transfusion Centers
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase the Report for Market-Driven Insights:
https://www.transparencymarketresearch.com/checkout.php?rep_id=85892<ype=S
Have a Look at More Valuable Insights of Healthcare
- Insufflation Devices Market: The global market for insufflation devices was estimated to be worth US$ 2.3 billion in 2021. The market is anticipated to advance with a 6.7% CAGR from 2022 to 2031 and by 2031; the market is likely to gain US$ 4.7 billion.
- Endodontic Files Market: The market for endodontic files was worth US$ 22.5 million in 2022. A 6.1% CAGR is expected from 2022 to 2032. The market is projected to reach US$ 40.7 million by 2032.
- On-body Drug Delivery Devices Market is expected to grow at a CAGR of 6.8% from 2024 to 2034 and reach US$ 796.1 Mn by the end of 2034
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/blood-transfusion-diagnostics-market-to-attain-a-valuation-of-us-7-7-billion-by-2034--rising-global-prevalence-of-blood-disorders-drives-growth-transparency-market-research-302205258.html
